The trajectory of companies tied to Viagra's past presents a complex investment scenario . While the initial success generated substantial returns , generic alternatives check here have significantly eroded revenue. Investing in associated pharmaceutical firms now requires a discerning assessment of patent safeguards, evolving healthcare changes, a